» Articles » PMID: 25231990

Sphingomyelin Synthase 2, but Not Sphingomyelin Synthase 1, is Involved in HIV-1 Envelope-mediated Membrane Fusion

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2014 Sep 19
PMID 25231990
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Membrane fusion between the viral envelope and plasma membranes of target cells has previously been correlated with HIV-1 infection. Lipids in the plasma membrane, including sphingomyelin, may be crucially involved in HIV-1 infection; however, the role of lipid-metabolic enzymes in membrane fusion remains unclear. In this study, we examined the roles of sphingomyelin synthase (SMS) in HIV-1 Env-mediated membrane fusion using a cell-cell fusion assay with HIV-1 mimetics and their target cells. We employed reconstituted cells as target cells that stably express Sms1 or Sms2 in Sms-deficient cells. Fusion susceptibility was ∼5-fold higher in Sms2-expressing cells (not in Sms1-expressing cells) than in Sms-deficient cells. The enhancement of fusion susceptibility observed in Sms2-expressing cells was reversed and reduced by Sms2 knockdown. We also found that catalytically nonactive Sms2 promoted membrane fusion susceptibility. Moreover, SMS2 co-localized and was constitutively associated with the HIV receptor·co-receptor complex in the plasma membrane. In addition, HIV-1 Env treatment resulted in a transient increase in nonreceptor tyrosine kinase (Pyk2) phosphorylation in Sms2-expressing and catalytically nonactive Sms2-expressing cells. We observed that F-actin polymerization in the region of membrane fusion was more prominent in Sms2-expressing cells than Sms-deficient cells. Taken together, our research provides insight into a novel function of SMS2 which is the regulation of HIV-1 Env-mediated membrane fusion via actin rearrangement.

Citing Articles

SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication.

Ali H, Naseem A, Siddiqui Z J Clin Med. 2023; 12(18).

PMID: 37763019 PMC: 10531702. DOI: 10.3390/jcm12186079.


Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.

Chen P, Wu M, He Y, Jiang B, He M Signal Transduct Target Ther. 2023; 8(1):237.

PMID: 37286535 PMC: 10244875. DOI: 10.1038/s41392-023-01510-8.


Lysophosphatidylinositol Induced Morphological Changes and Stress Fiber Formation through the GPR55-RhoA-ROCK Pathway.

Nakajima K, Oka S, Tanikawa T, Nemoto-Sasaki Y, Matsumoto N, Ishiguro H Int J Mol Sci. 2022; 23(18).

PMID: 36142844 PMC: 9504244. DOI: 10.3390/ijms231810932.


The Manifold Roles of Sphingolipids in Viral Infections.

Avota E, Bodem J, Chithelen J, Mandasari P, Beyersdorf N, Schneider-Schaulies J Front Physiol. 2021; 12:715527.

PMID: 34658908 PMC: 8511394. DOI: 10.3389/fphys.2021.715527.


Sphingolipids: Effectors and Achilles Heals in Viral Infections?.

Schneider-Schaulies S, Schumacher F, Wigger D, Schol M, Waghmare T, Schlegel J Cells. 2021; 10(9).

PMID: 34571822 PMC: 8466362. DOI: 10.3390/cells10092175.


References
1.
Jahn R, Lang T, Sudhof T . Membrane fusion. Cell. 2003; 112(4):519-33. DOI: 10.1016/s0092-8674(03)00112-0. View

2.
Chen Y, Siddhanta A, Austin C, Hammond S, Sung T, Frohman M . Phospholipase D stimulates release of nascent secretory vesicles from the trans-Golgi network. J Cell Biol. 1997; 138(3):495-504. PMC: 2141634. DOI: 10.1083/jcb.138.3.495. View

3.
Liu Y, Liu H, Kim B, Gattone V, Li J, Nath A . CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol. 2004; 78(8):4120-33. PMC: 374297. DOI: 10.1128/jvi.78.8.4120-4133.2004. View

4.
Rucker J, Doranz B, Edinger A, Long D, Berson J, Doms R . Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry. Methods Enzymol. 1997; 288:118-33. DOI: 10.1016/s0076-6879(97)88011-1. View

5.
Mitsutake S, Zama K, Yokota H, Yoshida T, Tanaka M, Mitsui M . Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes. J Biol Chem. 2011; 286(32):28544-55. PMC: 3151096. DOI: 10.1074/jbc.M111.255646. View